ADMA BIOLOGICS
ADMA is a specialty immune globulin company that develops, manufactures and intends to market plasma-based biologics targeted to niche patient populations for the treatment and prevention of certain infectious diseases. The Company’s target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease or who may be immune-suppressed for medical reasons. ADMA also operates ADMA BioCenters, FDA-licensed source plasma collection facilities which provide a portion of blood plasma for the manufacturing of the Company’s lead product candidate RI-002.
ADMA BIOLOGICS
Industry:
Biotechnology Health Care Manufacturing Medical
Founded:
2004-01-01
Address:
Ramsey, New Jersey, United States
Country:
United States
Website Url:
http://www.admabiologics.com
Total Employee:
51+
Status:
Active
Contact:
(201)478-5552
Email Addresses:
[email protected]
Total Funding:
547.35 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Google Universal Analytics Apache
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-06-06 | Biotest - Therapy business | Biotest - Therapy business acquired by ADMA Biologics | N/A |
Investors List
Hayfin Capital Management
Hayfin Capital Management investment in Post-IPO Debt - ADMA Biologics
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Debt - ADMA Biologics
Marathon Asset Management
Marathon Asset Management investment in Post-IPO Debt - ADMA Biologics
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - ADMA Biologics
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - ADMA Biologics
Hercules Capital
Hercules Capital investment in Post-IPO Debt - ADMA Biologics
Hercules Capital
Hercules Capital investment in Post-IPO Debt - ADMA Biologics
Hercules Capital
Hercules Capital investment in Debt Financing - ADMA Biologics
Biomark Capital
Biomark Capital investment in Venture Round - ADMA Biologics
Aisling Capital
Aisling Capital investment in Venture Round - ADMA Biologics
Official Site Inspections
http://www.admabiologics.com Semrush global rank: 2.07 M Semrush visits lastest month: 10.08 K
- Host name: 199.60.103.192
- IP address: 199.60.103.192
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
More informations about "ADMA Biologics"
ADMA Biologics, Inc. | LinkedIn
ADMA Biologics, Inc. | 9,519 followers on LinkedIn. Hiring at our Boca Raton, FL campus! | ADMA Biologics is an end-to-end commercial biopharmaceutical company dedicated to …See details»
ADMA Biologics, Inc. (ADMA) Company Profile & Facts - Yahoo …
See the company profile for ADMA Biologics, Inc. (ADMA) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
ADMA Biologics - Crunchbase Company Profile
ADMA Biologics develops plasma-based biologics for the treatment and …See details»
ADMA Biologics - LifeScienceHistory.com
ADMA Biologics is an end-to-end biopharmaceutical company with three FDA-licensed approved products including ASCENIVﾙ (Immune Globulin Intravenous – slra, Human), BIVIGAMﾮ …See details»
ADMA Biologics, Inc. (ADMA) - Official Website
ADMA Biologics is an end-to-end commercial biopharmaceutical company leading a new age of plasma-derived products with proven immunotechnologySee details»
ADMA Biologics - Craft
Oct 29, 2024 ADMA Biologics is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment …See details»
ADMA Biologics - PharmaSource
ADMA Biologics is a leading Contract Manufacturing Organisation (CMO) and Contract Development and Manufacturing Organisation (CDMO) that focuses on finished dosage …See details»
Adam Grossman - ADMA Biologics, Inc. | LinkedIn
I am the Founder, President and CEO of ADMA Biologics. I leveraged my deep experience in… · Experience: ADMA Biologics, Inc. · Education: American …See details»
Senior Leadership Team - ADMA Biologics, …
View the bios of our senior leadership, including our founder, executives, vice presidents, and senior directorsSee details»
ADMA Biologics, Inc. (ADMA) Company Profile & Facts - Yahoo …
See the company profile for ADMA Biologics, Inc. (ADMA) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
What We Do - ADMA Biologics, Inc. (ADMA)
We offer a full suite of CDMO and contract manufacturing organization (CMO) opportunities. Partner with us for your clinical-stage or commercial aseptic filling, packaging requirements, …See details»
ADMA Biologics Successfully Implements Innovative AI Program, …
Feb 21, 2024 Mr. Grossman continued, “The robust ADMAlytics AI program is designed to optimize and streamline our intricate production processes, delivering significant efficiencies …See details»
Company Info | ADMA Biologics, Inc.
Company Profile ADMA Biologics is an end-to-end commercial biopharmaceutical company committed to manufacturing, marketing, and developing specialty biologic products for the …See details»
Business Ethics & Compliance - ADMA Biologics
We employ analytics in our online training programs to gauge the effectiveness of the training. Each learning module reinforces the importance of the training, explains why it is essential, …See details»
ADMA Biologics Announces Preliminary Full Year 2024 Revenue …
Jan 13, 2025 RAMSEY, N.J. and BOCA RATON, Fla., Jan. 13, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end …See details»
ADMA Biologics Announces Second Quarter 2025 Financial …
1 day ago “The second quarter was another highly productive period for ADMA, highlighted by strong year-over-year underlying revenue and earnings growth, adjusting for a prior-year non …See details»
ADMA Biologics Announces U.S. FDA Approval of Innovative …
Approval Supports Revenue Growth and Margin Expansion Opportunity, and Substantially Increases Peak Production Output Capacity First U.S. Regulatory Approval of Innovative IG …See details»
ADMA Biologics Announces Second Quarter 2025 Financial …
7 hours ago “The second quarter was another highly productive period for ADMA, highlighted by strong year-over-year underlying revenue and earnings growth, adjusting for a prior-year non …See details»
Our Products - ADMA Biologics, Inc. (ADMA)
Commercial products: Our immune globulin product portfolio With three FDA-approved products, the mission of ADMA Biologics is to continue to successfully commercialize specialty biologics, …See details»
Careers - ADMA Biologics, Inc. (ADMA)
Shape the future, ours and yours. Work for a company that values its people by putting them first. Consider taking the next step in your careerSee details»